Rhinitis Allergic Seasonal
📧 Sign up to get email alerts when something new happens for Rhinitis Allergic Seasonal.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-10EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
Authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria in the EU.
-
EMA approval · 2026-07-10EMA Authorised: Desloratadine ratiopharm (desloratadine) — Ratiopharm GmbH
Authorised desloratadine product from Ratiopharm (desloratadine) for allergic rhinitis and urticaria indications in the EU.
-
EMA approval · 2022-06-24EMA Authorised: Desloratadine ratiopharm (desloratadine) — Ratiopharm GmbH
Authorised desloratadine product Desloratadine ratiopharm by Ratiopharm GmbH for allergic rhinitis and urticaria indications.
-
EMA approval · 2022-06-09EMA Authorised: Dasselta (desloratadine) — Krka, d.d., Novo mesto
Dasselta (desloratadine) by Krka has been authorised for allergic rhinitis (perennial and seasonal) and urticaria in the EU.
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis [Phase 2]
Phase 2 trial update for a drug targeting seasonal allergic rhinitis, completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis [Phase 2]
Phase 2 trial update of single-dose intranasal GSK256066 for allergic rhinitis shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Nasal Ocular Reflexes Contribute to Eye Symptoms [NA]
A clinical trial update indicates that nasal-ocular reflexes may contribute to eye symptoms in seasonal allergic rhinitis.
-
EMA withdrawal · 2011-11-17EMA Application withdrawn: Desloratadine Krka (desloratadine) — Krka, d.d., Novo mesto
The EMA withdrew the application for Desloratadine Krka, desloratadine, by Krka d.d., Novo mesto.
-
EMA withdrawal · 2011-10-18EMA Lapsed: Alisade (fluticasone furoate) — Glaxo Group Ltd.
The EMA lists Alisade (fluticasone furoate) as lapsed, with withdrawal of its marketing authorization in 2010.